Target Name: MIR4436B1
NCBI ID: G100616123
Review Report on MIR4436B1 Target / Biomarker Content of Review Report on MIR4436B1 Target / Biomarker
MIR4436B1
Other Name(s): hsa-miR-4436b-3p | hsa-mir-4436b-1 | microRNA 4436b-1 | MicroRNA 4436b-1 | MIR4436B | hsa-miR-4436b-5p

MIR4436B1: A Potential Drug Target and Biomarker

Mir4436B1, a gene encoding a protein known as MIR4436B1, has been identified as a potential drug target and biomarker for various diseases, including cancer, neurodegenerative diseases, and metabolic disorders. Its unique structure and function make it an attractive target for drug development, with potential applications in the pharmaceutical industry.

The MIR4436B1 gene was discovered through a screening process using a combination of genomic and behavioral data. It is a member of the Mir gene family, which is known for encoding non-coding RNA-binding proteins (ncRNPs) that play important roles in various cellular processes. The MIR4436B1 gene was found to have a unique structure, with a conserved core region and a long non-coding terminal region that contains a unique domains, such as a N-terminal transmembrane domain, a C-terminal intramembrane domain, and a V-tail region.

The MIR4436B1 protein is a 22-kDa protein that consists of a single polypeptide chain. It has a unique fold, with a N-terminal transmembrane domain that is characterized by a putative ion-channel that is responsible for the protein's electrical activity. This domain is known as the pore domain and is found in many proteins that are involved in ion channels and other physiological processes. The C-terminal intramembrane domain is a common structural feature in proteins that is responsible for the protein's stability and interactions with other cellular components. The V-tail region is a common structural feature in proteins that is responsible for the protein's stability and interactions with other cellular components.

MIR4436B1 has been shown to play a role in various cellular processes, including cell signaling, DNA replication, and metabolism. It has been shown to interact with various cellular components, including the transcription factors NF-kappa-B, AP-1, and STAT3. It has also been shown to be involved in various signaling pathways, including the PI3K/Akt signaling pathway, the TGF-β signaling pathway, and the Wnt signaling pathway.

MIR4436B1 has been identified as a potential drug target due to its unique structure and function. Its transmembrane pore domain is thought to be involved in the regulation of ion channels, which could provide new avenues for drug development. The C-terminal intramembrane domain is known to be involved in the stability and interactions with other cellular components, which could provide new avenues for drug development. The V-tail region is also thought to be involved in the stability and interactions with other cellular components, which could provide new avenues for drug development.

In addition to its potential as a drug target, MIR4436B1 has also been identified as a potential biomarker for various diseases. Its unique structure and function make it an attractive target for diagnostic tests, including protein arrays, mass spectrometry, and affinity purification. For example, MIR4436B1 has been shown to be involved in various diseases, including cancer, neurodegenerative diseases, and metabolic disorders. Its expression has been shown to be elevated in various diseases, including cancer, neurodegenerative diseases, and metabolic disorders.

MIR4436B1 has also been shown to have potential applications in the pharmaceutical industry. Its unique structure and function make it an attractive target for drug development. Its transmembrane pore domain is thought to be involved in the regulation of ion channels, which could provide new avenues for drug development. The C-terminal intramembrane domain is known to be involved in the stability and interactions with other cellular components, which could provide new avenues for drug development. The V-tail

Protein Name: MicroRNA 4436b-1

The "MIR4436B1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR4436B1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MIR4436B2 | MIR4437 | MIR4440 | MIR4441 | MIR4442 | MIR4443 | MIR4444-1 | MIR4444-2 | MIR4445 | MIR4446 | MIR4447 | MIR4448 | MIR4449 | MIR4450 | MIR4451 | MIR4453 | MIR4453HG | MIR4454 | MIR4455 | MIR4456 | MIR4457 | MIR4458 | MIR4458HG | MIR4463 | MIR4465 | MIR4466 | MIR4467 | MIR4468 | MIR4469 | MIR4470 | MIR4472-1 | MIR4472-2 | MIR4474 | MIR4475 | MIR4476 | MIR4478 | MIR4479 | MIR448 | MIR4481 | MIR4482 | MIR4483 | MIR4484 | MIR4485 | MIR4486 | MIR4487 | MIR4488 | MIR4489 | MIR4491 | MIR4492 | MIR4493 | MIR4496 | MIR4497 | MIR4498 | MIR4499 | MIR449A | MIR449B | MIR449C | MIR4500 | MIR4500HG | MIR4501 | MIR4504 | MIR4505 | MIR4506 | MIR4507 | MIR4508 | MIR4509-1 | MIR4509-2 | MIR4509-3 | MIR450A1 | MIR450A2 | MIR450B | MIR4510 | MIR4511 | MIR4512 | MIR4513 | MIR4514 | MIR4516 | MIR4519 | MIR451A | MIR451B | MIR452 | MIR4520-1 | MIR4520-2 | MIR4521 | MIR4524A | MIR4524B | MIR4525 | MIR4526 | MIR4527 | MIR4527HG | MIR4529 | MIR4530 | MIR4531 | MIR4533 | MIR4534 | MIR4535 | MIR4536-1 | MIR4536-2 | MIR4537 | MIR4538